Assessment of anti-endothelial cell antibodies in systemic sclerosis and Sjogren's syndrome

Annals of the Rheumatic Diseases

Volumn 56, Issue 4, 1997, Pages 230-234

  Hebbar, Mohamed ^a,b   Lassalle, Philippe ^a   Delneste, Yves ^a   Hatron, Pierre Yves ^a   Devulder, Bernard ^a   Tonnel, André Bernard ^a   Janin, Anne ^a  

^a Service de médecine nucléaire HÔpital Huriez   (France)

^b LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANTIBODY DETECTION; ARTICLE; CLINICAL ARTICLE; COLLAGEN SYNTHESIS; CONTROLLED STUDY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; RAYNAUD PHENOMENON; SJOEGREN SYNDROME; SYSTEMIC SCLEROSIS; VASCULITIS;

EID: 0031001461     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.56.4.230     Document Type: Article

References (21)

1. Fleischmajer R. The pathophysiology of scleroderma. Int J Dermatol 1977;16:310-8.
2. Campbell PM, LeRoy EC. Pathogenesis of systemic sclerosis: a vascular hypothesis. Arthritis Rheum 1975;4:51-68.
3. Hebbar M, Lassalle P, Janin A, Vanhée D, Bisiau S, Hatron PY, et al. E-selectin expression in salivary endothelial cells and sera of patients with systemic sclerosis. Role of resident mast cell-derived tumor necrosis factor alpha (TNF α). Arthritis Rheum 1995;38:406-12.
4. Hebbar M, Gillot JM, Hachulla E, Lassalle P, Hatron PY, Devulder B, et al. E-selectin expression on salivary endothelial cells in patients with Raynaud's phenomenon and abnormal nailfold capillaroscopy. Predictive value for progression to systemic sclerosis. Arthritis Rheum 1996; 39:1161-5.
5. Marks RM, Czerniecki M, Andrews BS, Penny R. The effects of scleroderma serum on human microvascular endothelial cells. Arthritis Rheum 1988;31:1524-34.
6. Penning CA, Cunningham J, French MAH, Harrisson G, Rowell NR, Hughes P. Antibody-dependent cellular cytotoxicity of human vascular endothelium in systemic sclerosis. Clin Exp Immunol 1984;58:548-56.
7. Rosenbaum J, Pottinger BE, Woo P, Black CM, Loizou S, Byron MA, et al. Measurement and characterization of circulating anti-endothelial cell IgG in connective tissue diseases. Clin Exp Immunol 1988;72:450-6.
8. Heurkens AHM, Hiemstra PS, Lafeber GJM, Daha MR, Breedveld FC. Anti-endothelial cell antibodies in patients with rheumatoid arthritis complicated by vasculitis. Clin Exp Immunol 1989;78:359-65.
9. Leung DYM, Collins T, Lapierre LA, Geha RS, Pober JS. Immunoglobulin M antibodies present in the acute phase of Kawasaki syndrome lyse cultured vascular endothelial cells stimulated by gamma interferon. J Clin Invest 1986;77:1428-35.
10. Yoshio T, Masuyama JI, Sumiya M, Minota S, Kano S. Antiendothelial cell antibodies and their relation to pulmonary hypertension in systemic lupus erythematosus. J Rheumatol 1994; 21:2058-63.
11. D'Cruz DP, Houssiau FA, Ramirez G, Baguley E, McCutcheon J, Vianna J, et al. Antibodies to endothelial cells in systemic lupus erythematosus: a potential marker for nephritis and vasculitis. Clin Exp Immunol 1991; 85:254-61.
12. D'Cruz DP, Wisniewski JJ, Asherson RA, Khamashta MA, Hughes GR. Autoantibodies in systemis lupus erythematosus and urticarial vasculitis. J Rheumatol 1995;22: 1669-73.
13. Janin A, Gosselin D, Gosset D, Hatron PY, Sauvezie B. Histotogical criteria of Sjögren's syndrome in scleroderma. Clin Exp Rheumatol 1989;7:167-9.
14. Hebbar M, Janin A, Huglo D, Copin MC, Lafyatis R, Devulder B, et al. Xerostomia in progressive systemic sclerosis. Systematic evaluation by salivary scintigraphy and lip biopsy in 34 patients. Arthritis Rheum 1994;37:439-11.
15. Janin A, Konttinen YT, Grönblad M, Karhunen P, Gosset D, Malmström M. Fibroblast markers in labial salivary gland biopsies in progressive systemic sclerosis. Clin Exp Rheumatol 1990;8:237-42.
16. Coll J, Rives A, Grino MC, Setoain J, Vivancos J, Balcells A. Prevalence of Sjögren's syndrome in autoimmune diseases. Ann Rheum Dis 1987;46:286-9.
17. Alexander EL, Arnett FC, Provost TT. Sjögren's syndrome: association of anti-Ro (SSA) antibodies with vasculitis, hematologic abnormalities and serologic hyperactivity. Ann Intern Med 1983;98:155-9.
18. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee: Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980;23:581-90.
19. Manthorpe R, Oxholm P, Prause Ju, Schiodt M. The Copenhagen criteria for Sjögren's syndrome. Scand J Rheumatol 1986;61:19-21.
20. Lassalle P, Gosset P, Gruart V, Prin L, Capron M, Lagrue G, et al. Presence of antibodies against endothelial cells in the sera of patients with episodic angioedema and hypereosinophilia. Clin Exp Immunol 1990;82:38-43.
21. Cines DB, Lyss AP, Reeber M, Bina M, DeHoratius RJ. Presence of complement-fixing anti-endothelial cell antibodies in systemic lupus erythematosus. J Clin Invest 1984;73:611-25.